EVOFEM BIOSCIENCES INC (EVFM) Stock Analyst Earnings Estimates
NASDAQ:EVFM - Nasdaq - US30048L2034 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 450K | 8.244M 1,732.00% | 32.556M 294.91% | 61.392M 88.57% | 101.25M 64.92% | 175.449M 73.28% | 310.104M 76.75% | ||
| EBITDA YoY % growth | -52.48M 32.18% | -103.32M -96.88% | -165.778M -60.45% | -101.133M 38.99% | -61.45M 39.24% | -41.382M 32.66% | -55.155M -33.28% | -74.982M -35.95% | |
| EBIT YoY % growth | -52.74M 32.07% | -103.62M -96.47% | -166.801M -60.97% | -92.929M 44.29% | -71.467M 23.10% | -41.448M 42.00% | -53.862M -29.95% | -71.394M -32.55% | |
| Operating Margin | N/A | -23,026.67% | -2,023.30% | -285.44% | -116.41% | -40.94% | -30.70% | -23.02% | |
| EPS YoY % growth | -1.49 53.29% | -2.18 -46.31% | -12.98 -495.41% | -5.47 57.85% | -1.19 78.31% | -0.59 50.14% | -0.95 -61.01% | -1.56 -64.23% |
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.03 67.32% | % | ||
| Q4 2023 Q2Q % growth | 71.20% | -0.09 | % | |
| Q3 2023 Q2Q % growth | 74.57% | -0.11 | % | |
| Q2 2023 Q2Q % growth | 89.80% | -0.10 | % | |
| Q1 2023 Q2Q % growth | 96.10% | -0.11 | % | |
| Q4 2022 Q2Q % growth | 93.56% | -0.32 | % | |
| Q3 2022 Q2Q % growth | 93.87% | -0.44 | % | |
| Q2 2022 Q2Q % growth | -270.22% | -1.00 | % | |
| Q1 2022 Q2Q % growth | -2.88 -414.29% | -3.06 | 0.18 | 5.88% |
| Q4 2021 Q2Q % growth | -4.95 -890.00% | -3.48 | -1.47 | -42.21% |
| Q3 2021 Q2Q % growth | -7.20 -1,845.95% | -4.51 | -2.69 | -59.52% |
| Q2 2021 Q2Q % growth | -0.27 70.33% | -0.37 | 0.10 | 27.97% |
| Q1 2021 Q2Q % growth | -0.56 -40.00% | -0.50 | -0.06 | -12.62% |
| Q4 2020 Q2Q % growth | -0.50 -85.19% | -0.37 | -0.13 | -35.23% |
| Q3 2020 Q2Q % growth | -0.37 -23.33% | -0.45 | 0.08 | 17.56% |
| Q2 2020 Q2Q % growth | -0.91 -121.95% | -0.38 | -0.53 | -138.97% |
| Q1 2020 Q2Q % growth | -0.40 21.57% | -0.33 | -0.07 | -22.55% |
| Q4 2019 Q2Q % growth | -0.27 | -0.29 | 0.02 | 8.09% |
| Q3 2019 Q2Q % growth | -0.30 | -0.32 | 0.02 | 5.73% |
| Q2 2019 Q2Q % growth | -0.41 | -0.38 | -0.03 | -8.05% |
| Q1 2019 Q2Q % growth | -0.51 | -0.42 | -0.09 | -22.55% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 7.1M -69.87% | % | ||
| Q4 2023 Q2Q % growth | 90.20% | 23.562M | % | |
| Q3 2023 Q2Q % growth | 92.33% | 17.85M | % | |
| Q2 2023 Q2Q % growth | 163.13% | 16.014M | % | |
| Q1 2023 Q2Q % growth | 233.52% | 14.178M | % | |
| Q4 2022 Q2Q % growth | 247.00% | 12.388M | % | |
| Q3 2022 Q2Q % growth | 442.11% | 9.281M | % | |
| Q2 2022 Q2Q % growth | 227.73% | 6.086M | % | |
| Q1 2022 Q2Q % growth | 4.251M 282.97% | 4.641M | -390K | -8.40% |
| Q4 2021 Q2Q % growth | 3.57M 2,000.00% | 3.424M | 146.197K | 4.27% |
| Q3 2021 Q2Q % growth | 1.712M 511.43% | 3.455M | -1.743M | -50.45% |
| Q2 2021 Q2Q % growth | 1.857M | 2.738M | -880.68K | -32.17% |
| Q1 2021 Q2Q % growth | 1.11M | 1.661M | -550.56K | -33.16% |
| Q4 2020 Q2Q % growth | 170K | 1.721M | -1.551M | -90.12% |
| Q3 2020 Q2Q % growth | 280K | 1.757M | -1.477M | -84.06% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |